ID
816
Description
NSABP PROTOCOL B-35 Treatment Form for Tamoxifen/Anastrozole Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A051E957-2260-0392-E034-080020C9C0E0
Link
Keywords
Versions (3)
- 8/26/12 8/26/12 -
- 5/22/15 5/22/15 -
- 6/3/15 6/3/15 -
Uploaded on
August 26, 2012
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0 Legacy
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Breast Cancer NCT00053898 Treatment - NSABP PROTOCOL B-35 Treatment Form for Tamoxifen/Anastrozole - 2033974v3.0
Form T (04-30-2002) Submit this form when Tamoxifen/Anastrozole therapy has ended or if the patient did not begin Tamoxifen/Anastrozole.
- StudyEvent: NSABP PROTOCOL B-35 Treatment Form for Tamoxifen/Anastrozole
Description
Summary Of Tamoxifen/anastrozole Administration
Description
Unnamed2
Similar models
Form T (04-30-2002) Submit this form when Tamoxifen/Anastrozole therapy has ended or if the patient did not begin Tamoxifen/Anastrozole.
- StudyEvent: NSABP PROTOCOL B-35 Treatment Form for Tamoxifen/Anastrozole
C0027361 (UMLS 2011AA ObjectClass)
C25364 (NCI Thesaurus Property)
C0600091 (UMLS 2011AA Property)
C1527021 (UMLS 2011AA ValueDomain)
C1511726 (UMLS 2011AA ObjectClass)
C25416 (NCI Thesaurus Property)
C1691222 (UMLS 2011AA Property)
C1705108 (UMLS 2011AA)
C1298908 (UMLS 2011AA)
C0205394 (UMLS 2011AA)